Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/3800| Title: | New Microbiological Techniques for the Diagnosis of Bacterial Infections and Sepsis in ICU Including Point of Care | Authors: | Peri, A. M.;Irwin, Adam ;Harris, P. N. A.;Stewart, A.;Hume, A. | Issue Date: | 2021 | Source: | 23, (8), 2021 | Journal: | Current Infectious Disease Reports | Abstract: | Purpose of Review: The aim of this article is to review current and emerging microbiological techniques that support the rapid diagnosis of bacterial infections in critically ill patients, including their performance, strengths and pitfalls, as well as available data evaluating their clinical impact. Recent Findings: Bacterial infections and sepsis are responsible for significant morbidity and mortality in patients admitted to the intensive care unit and their management is further complicated by the increase in the global burden of antimicrobial resistance. In this setting, new diagnostic methods able to overcome the limits of traditional microbiology in terms of turn-around time and accuracy are highly warranted. We discuss the following broad themes: optimisation of existing culture-based methodologies, rapid antigen detection, nucleic acid detection (including multiplex PCR assays and microarrays), sepsis biomarkers, novel methods of pathogen detection (e.g. T2 magnetic resonance) and susceptibility testing (e.g. morphokinetic cellular analysis) and the application of direct metagenomics on clinical samples. The assessment of the host response through new “omics” technologies might also aid in early diagnosis of infections, as well as define non-infectious inflammatory states. Summary: Despite being a promising field, there is still scarce evidence about the real-life impact of these assays on patient management. A common finding of available studies is that the performance of rapid diagnostic strategies highly depends on whether they are integrated within active antimicrobial stewardship programs. Assessing the impact of these emerging diagnostic methods through patient-centred clinical outcomes is a complex challenge for which large and well-designed studies are awaited.L20128378122021-06-22 | DOI: | 10.1007/s11908-021-00755-0 | Resources: | https://www.embase.com/search/results?subaction=viewrecord&id=L2012837812&from=exporthttp://dx.doi.org/10.1007/s11908-021-00755-0 | | Keywords: | blood culture;bloodstream infection;candidemia;cost effectiveness analysis;critically ill patient;disease surveillance;disk diffusion;Enterococcus faecium;enzyme immunoassay;Escherichia coli;fluorescence in situ hybridization;gene expression;high throughput sequencing;hospital readmission;human;immune response;immunomodulation;intensive care unit;Klebsiella pneumoniae;length of stay;machine learning;metagenomics;microbiological examination;microfluidics;microorganism detection;minimum inhibitory concentration;morbidity;mortality;multiplex polymerase chain reaction;nuclear magnetic resonance;nucleic acid analysis;patient care;pharmacokinetic parameters;pleura fluid;point of care testing;predictive value;red blood cell distribution width;respiratory tract infection;review;sensitivity and specificity;sepsis;septic shock;Pseudomonas aeruginosa;Staphylococcus aureus;systematic review;antibiotic agentcarbapenemase;extended spectrum beta lactamase;fluconazole;flucytosine;interleukin 6;isavuconazole;meropenem;procalcitonin;RNA 16S;Acinetobacter baumannii;acute kidney failure;antibiotic resistance;bacterial infection;bacterial meningitis;bacterium identification | Type: | Article |
| Appears in Sites: | Children's Health Queensland Publications Queensland Health Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.